Merck Cash on Hand 2010-2025 | MRK

Merck cash on hand for the quarter ending March 31, 2025 was $9.228B, a 64.23% increase year-over-year.

  • Merck cash on hand for 2024 was $13.689B, a 92.99% increase from 2023.
  • Merck cash on hand for 2023 was $7.093B, a 46.23% decline from 2022.
  • Merck cash on hand for 2022 was $13.192B, a 62.94% increase from 2021.

Merck Cash on Hand 2010-2025 | MRK

  • Merck cash on hand for 2024 was $13.689B, a 92.99% increase from 2023.
  • Merck cash on hand for 2023 was $7.093B, a 46.23% decline from 2022.
  • Merck cash on hand for 2022 was $13.192B, a 62.94% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B